DOCK8 missense mutations have been shown to diminish lymphocyte cytolytic activity in CSS patients with infection triggered CSS, autoimmune triggered CSS, as well as the post-COVID-19 CSS, MIS-C [20,22]. The gene discussed is DOCK8; the disease is COVID-19.